Table 1.
Patient characteristics
| Acitretin | Control | P‐value | ||
|---|---|---|---|---|
| Number of patients | 22 | 79 | ||
| Age at first transplant, median (IQR) | 49.5 (44, 55) | 50 (39, 58) | 0.80 | |
| Age at acitretin commencement/control study commencement, median (IQR) | 58.5 (53, 66) | 54 (47, 62) | 0.037 | |
| Years since first transplant, median (IQR) | 12 (8, 15) | 4 (1, 9) | <0.001 | |
| Years of follow‐up after acitretin commencement/control study commencement, median (IQR) | 5.5 (4.7, 7.7) | 5.9 (3.8, 8.8) | 0.64 | |
| Sex | Male | 19 (86%) | 50 (63%) | 0.042 |
| Female | 3 (14%) | 29 (37%) | ||
| Skin phototype | 1 | 4 (18%) | 11 (14%) | 0.92 |
| 2 | 7 (32%) | 26 (33%) | ||
| 3 | 7 (32%) | 23 (29%) | ||
| 4 | 2 (9%) | 6 (8%) | ||
| Not documented | 2 (9%) | 13 (16%) | ||
| Organ(s) transplanted | Renal | 16 (73%) | 66 (84%) | 0.33 |
| Heart | 4 (18%) | 5 (6%) | ||
| Liver | 1 (5%) | 3 (4%) | ||
| Lung | 1 (5%) | 2 (3%) | ||
| Renal and pancreas | 0 (0%) | 3 (4%) | ||
IQR, interquartile range.